17 May 2000 Pilot study: intravenous use of indocyanine green as an enhancer for 808-nm diode laser application in the equine
Author Affiliations +
Proceedings Volume 3907, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems X; (2000) https://doi.org/10.1117/12.386286
Event: BiOS 2000 The International Symposium on Biomedical Optics, 2000, San Jose, CA, United States
Abstract
The 808-nm diode laser, delivering 20 - 40 watts of power, has been produced for medical applications by several manufacturers over the past 10 years. This laser's power output is less than most Neodymium:yttrium aluminum garnet (Nd:YAG) lasers and other high power cutting lasers that use fiberoptic delivery systems. The 808-nm diode laser has not gained popularity in equine transendoscopic laser surgery. Indocyanine green (ICG) is absorbed at 810-nm of light which when concentrated in tissue should be an excellent absorber for the energy produced by the 808-nm diode laser. This study compares the depths and widths of penetration achieved with the 808-nm diode laser after intravenous injection of ICG in equine respiratory tissue. Indocyanine green was administered at two doses: 1.5 mg/kg and 3 mg/kg. The 808-nm diode laser was set to deliver 200 joules of energy. The depths and widths of penetration were also compared to the Nd:YAG laser applied at the same energy setting.
© (2000) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Lloyd P. Tate, Lloyd P. Tate, Anthony T. Blikslager, Anthony T. Blikslager, Mark G. Papich, Mark G. Papich, } "Pilot study: intravenous use of indocyanine green as an enhancer for 808-nm diode laser application in the equine", Proc. SPIE 3907, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems X, (17 May 2000); doi: 10.1117/12.386286; https://doi.org/10.1117/12.386286
PROCEEDINGS
7 PAGES


SHARE
Back to Top